Increased incidence of narcolepsy following the 2009 H1N1 pandemic

Somnologie

Volumn 17, Issue 2, 2013, Pages 90-93

  Zhang, X Z ^a   Penzel, T ^b   Han, F ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

HLA antigens; Incidence; Influenza A, H1N1 subtype; Orexins; Vaccines

Indexed keywords

HLA DQB1 ANTIGEN; HLA DR2 ANTIGEN; INFLUENZA VACCINE; OREXIN A;

2009 H1N1 INFLUENZA; ARTICLE; CATAPLEXY; CHINA; CLINICAL FEATURE; DRUG SAFETY; FINLAND; GROUPS BY AGE; HUMAN; INCIDENCE; INFLUENZA A (H1N1); INFLUENZA VACCINATION; NARCOLEPSY; SWEDEN; SYSTEMATIC REVIEW; T LYMPHOCYTE;

EID: 84879963240     PISSN: 14329123     EISSN: 1439054X     Source Type: Journal    
DOI: 10.1007/s11818-013-0619-8     Document Type: Article

References (28)

1. European Centre for Disease Prevention and Control (2012) Narcolepsy in association with pandemic influenza vaccination (a multi-country European epidemiological investigation). ECDC, Stockholm. http://www.ecdc.europa.eu/en/ publications/publications/vaesco%20report%20final%20with%20cover.pdf. Accessed 25 May 2013
2. Dauvilliers Y, Montplaisir J, Molinari N et al (2001) Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology 57:2029-2033 (Pubitemid 33126870)
3. Käll A (2013) The Pandemrix-narcolepsy tragedy: how it started and what we know today. Acta Paediatr 102(1):2-4
4. Dauvilliers Y, Montplaisir J, Cochen V et al (2010) Post-H1N1 narcolepsy-cataplexy. Sleep 33(11):1428-1430
5. Partinen M, Saarenpää-Heikkilä O, Ilveskoski I et al (2012) Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One 7(3):
6. Nohynek H, Jokinen J, Partinen M et al (2012) AS03-adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One 7(3):e33536
7. Wijnans L Lecomte C, de Vries C et al (2013) The incidence of narcolepsy in Europe: before, during, and after the influenza A (H1N1) pdm09 pandemic and vaccination campaigns. Vaccine 31:1246-12654
8. Miller E, Andrews N, Stellitano L et al (2013) Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. BMJ 346:f794
9. Bardage C, Persson I, Ortqvist A et al (2011) Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden. BMJ 343:d5956
10. Kallweit U, Hidalgo H, Engel A et al (2012) Post H1N1 vaccination narcolepsy-cataplexy with decreased CSF beta-amyloid. Sleep Med 13:321-323
11. Oberle D, Pönisch C, Mayer G, Keller-Stanislawski B (2013) Case-control study on risk factors of narcolepsy in Germany. Somnologie Schlafforschung und Schlafmed
12. Schnirring L (2013) French study finds narcolepsy link to H1N1 vaccine in adults. http://www.cidrap.umw.edu/cidrap/content/influenza/suineflu/news/ sep2012narcolepsy.html
13. Han F, Lin L, Warby SC et al (2011) Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol 70(3):410-417
14. Han F, Lin L, Li J et al (2012) Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic. Ann Neurol 73:560
15. Choe YJ, Bae GR, Lee DH (2012) No association between influenza A (H1N1) pdm09 vaccination and narcolepsy in South Korea: an ecological study. Vaccine 30:7439-7442
16. Faraco J, Mignot E (2011) Immunological and genetic aspects of narcolepsy. Sleep Med Res 2:1-9
17. Juji T, Satake M, Honda Y, Doi Y (1984) HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive. Tissue Antigens 24(5):316-319 (Pubitemid 15199473)
18. Mignot E, Lin L, RogersW et al (2001) Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 68:686-699 (Pubitemid 32202763)
19. Han F, Lin L et al (2012) HLA-DQ association and allele competition in Chinese narcolepsy. Tissue Antigens 80(4):328-335
20. Hallmayer J, Faraco J, Lin L et al (2009) Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet 41:708e11
21. Tafti M et al (2010) Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J Clin Invest 120(3):713-719
22. Kawashima M, Lin L, Tanaka S et al (2010) Anti-Tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy. Sleep 33(7):869-874
23. Faraco J, Lin L, Mignot E (2013) ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLos Genet 9(2)
24. Picchioni D, Hope CR, Harsh JR (2007) A case control study of the environmental risk factors for narcolepsy. Neuroepidemiology 29:185-192 (Pubitemid 351197521)
25. Koepsell TD, LongstrethWT, Ton TG (2009) Medical exposures in youth and the frequency of narcolepsy with cataplexy: a population based case-control study in genetically predisposed people. J Sleep Res 19:80-86
26. Aran A, Lin L, Nevsimalova S et al (2009) Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep 32:979-983
27. Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR (2011) Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acid Res 39:D913-D919
28. Singh AK et al (2013) Genetic association, seasonal infections and autoimmune basis of narcolepsy. J Autoimmun. Epub ahead of print. doi: 10.1016/j.jaut.2013.02.003